<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-3728</title>
	</head>
	<body>
		<main>
			<p>941212 FT  12 DEC 94 / People (Names in the News): Humer homes in on Roche Roche, the Swiss pharmaceuticals group, has once again shown its opportunistic flair for snatching a top executive from a rival, writes Ian Rodger. This time it is Franz Humer, a becalmed number two at Glaxo, who will move to Basle next year to head Roche's drugs division. Humer will replace the retiring Armin Kessler, whom Roche grabbed from its Basle neighbour Sandoz in 1982. Jurgen Drews, R&amp;D director, is also a Sandoz alumnus. Humer, 48, an Austrian turned Swiss, is also a member of another group: graduates of the Schering-Plough European executive apprenticeship programme in Lucerne. In the 1970s, Max von Dach, then head of Schering Europe, started the practice of hiring a promising young graduate as his personal assistant. Humer, a graduate of the University of Innsbruck and Insead, was the first of several to go on to distinguished careers. He was followed by Peter Simon, head of Roche pharmaceuticals until last month, Jean-Pierre Garnier, chairman of SB Pharmaceuticals, Jean-Charles Tschudin, former president of Syntex in Europe, and Hans-Jorg Kummer, the boss of Schering-Plough Europe. Humer has gone to ground since last week, but former colleagues and acquaintances describe him as being demanding with a touch of arrogance. 'He is good at getting what he wants. Roche's country managers will find him more difficult than Peter Simon,' one said. Max von Dach recalls that Humer was 'always ahead of the others', and seemed confident he would adjust to life at the austere Roche. 'He is a very flexible guy. At least he was when I knew him.'</p>
		</main>
</body></html>
            